Sanofi Stock Forecast

Stock Price Forecast

According to 10 analysts polled by S&P Global, Sanofi stock has a consensus rating of "Buy" and an average price target of $53.72. The average 1-year stock price forecast is 21.43% higher than the current stock price, while the lowest is $45 (+1.72%) and the highest is $63 (+42.41%).

Price Target: $53.72 (+21.43%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$45	$53.72	$54.5	$63
Change	+1.72%	+21.43%	+23.19%	+42.41%

Analyst Ratings

The average analyst rating for Sanofi stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	Mar '26	Apr '26	May '26	Jun '26	Jul '26	Aug '26
Strong Buy	4	4	4	5	5	5
Buy	3	2	1	0	0	0
Hold	3	4	5	5	5	5
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	10	10	10	10	10

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Steve Scala TD Cowen	TD Cowen	Hold Maintains $57	Hold	Maintains	$57	+28.84%	Aug 31, 2026
Unknown Analyst Berenberg Bank No rating	Berenberg Bank	Buy Maintains $62	Buy	Maintains	$62	+40.14%	Aug 24, 2026
Seamus Fernandez Guggenheim	Guggenheim	Hold Maintains n/a	Hold	Maintains	n/a	n/a	Jul 10, 2026
Sarita Kapila Morgan Stanley	Morgan Stanley	Hold Maintains $52 → $49	Hold	Maintains	$52 → $49	+10.76%	Jul 8, 2026
Peter Verdult Exane BNP Paribas	Exane BNP Paribas	Hold Downgrades $50	Hold	Downgrades	$50	+13.02%	Apr 20, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

47.68B

from 46.72B

2.07%

from 46.72B

Revenue Next Year

50.81B

from 47.68B

6.56%

from 47.68B

EPS This Year

8.56

from 7.83

9.38%

from 7.83

EPS Next Year

9.06

from 8.56

5.79%

from 8.56

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	39.18B	40.30B	41.11B	44.29B	46.72B	47.68B
Revenue Growth	4.83%	2.88%	2.00%	7.73%	5.49%	2.07%
Gross Profit	26.92B	28.44B	28.49B	31.09B	33.79B	36.36B
Gross Margin	68.73%	70.55%	69.30%	70.21%	72.34%	76.26%
Operating Income	8.57B	10.38B	8.12B	8.87B	9.65B	13.21B
Net Income	6.22B	8.37B	5.40B	5.56B	7.81B	7.91B
EPS	-	-	-	-	7.83	8.56
EPS Growth	-	-	-	-	9.97%	9.38%
Forward PE	-	-	-	-	-	8.89
Dividend / Share	3.33	3.56	3.76	3.92	4.12	4.25
Dividend Growth	4.06%	6.91%	5.62%	4.26%	5.10%	3.26%
Free Cash Flow	7.34B	8.51B	7.17B	-4.94B	16.64B	8.31B
No. Analysts	-	-	-	-	-	11

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	48.1B
Avg	47.7B
Low	46.3B

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	3.1%
Avg	2.1%
Low	-0.8%

EPS Forecast

Chart

EPS	2026	2027	2028
High	8.93
Avg	8.56
Low	8.09

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	14.0%
Avg	9.4%
Low	3.3%